1
|
Fan Z, Lali MN, Xiong H, Luo Y, Wang Y, Wang Y, Lu M, Wang J, He X, Shi X, Zhang Y. Seedlings of Poncirus trifoliata exhibit tissue-specific detoxification in response to NH 4 + toxicity. Plant Biol (Stuttg) 2024; 26:467-475. [PMID: 38466186 DOI: 10.1111/plb.13621] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/19/2023] [Accepted: 01/18/2024] [Indexed: 03/12/2024]
Abstract
Ammonium nitrogen (NH4 +-N) is essential for fruit tree growth, but the impact of excess NH4 +-N from fertilizer on evergreen citrus trees is unclear. In a climate chamber, 8-month-old citrus plants were exposed to five different hydroponic NH4 +-N concentrations (0, 5, 10, 15 and 20 mm) for 1 month to study effects of NH4 +-N on growth characteristics, N uptake, metabolism, antioxidant enzymes and osmotic regulatory substances. Application of 10 mm NH4 +-N adversely affected root plasma membrane integrity, root physiological functions, and plant biomass. MDA, CAT, POD, APX and SOD content were significantly correlated with leaf N metabolic enzyme activity (GOGAT, GDH, GS and NR). GDH was the primary enzyme involved in NH4 +-N assimilation in leaves, while the primary pathway involved in roots was GS-GOGAT. Under comparatively high NH4 + addition, roots were the main organs involved in NH4 + utilization in citrus seedlings. Our results demonstrated that variations in NH4 + concentration and enzyme activity in various organs are associated with more effective N metabolism in roots than in leaves to prevent NH4 + toxicity in evergreen woody citrus plants. These results provide insight into the N forms used by citrus plants that are important for N fertilizer management.
Collapse
Affiliation(s)
- Z Fan
- College of Resources and Environment, Southwest University, Chongqing, China
- College of Natural Resources and Environment, Northwest A&F University, Yangling, Shaanxi, China
| | - M N Lali
- College of Resources and Environment, Southwest University, Chongqing, China
- Department of Forestry and Natural Resources, Faculty of Agriculture, Bamyan University, Bamyan, Afghanistan
| | - H Xiong
- College of Resources and Environment, Southwest University, Chongqing, China
| | - Y Luo
- College of Resources and Environment, Southwest University, Chongqing, China
| | - Y Wang
- College of Resources and Environment, Southwest University, Chongqing, China
- Interdisciplinary Research Center for Agriculture Green Development in Yangtze River Basin, Southwest University, Chongqing, China
| | - Y Wang
- Development and Guidance Station of Cereal and Oil Crops in Hechuan District, Chongqing, China
| | - M Lu
- College of Resources and Environment, Southwest University, Chongqing, China
- Chongqing Agro-Tech Extension Station, Chongqing, China
| | - J Wang
- College of Resources and Environment, Southwest University, Chongqing, China
- Interdisciplinary Research Center for Agriculture Green Development in Yangtze River Basin, Southwest University, Chongqing, China
| | - X He
- College of Resources and Environment, Southwest University, Chongqing, China
| | - X Shi
- College of Resources and Environment, Southwest University, Chongqing, China
- Interdisciplinary Research Center for Agriculture Green Development in Yangtze River Basin, Southwest University, Chongqing, China
| | - Y Zhang
- College of Resources and Environment, Southwest University, Chongqing, China
- Interdisciplinary Research Center for Agriculture Green Development in Yangtze River Basin, Southwest University, Chongqing, China
| |
Collapse
|
2
|
Dai C, Xiong H, He R, Zhu C, Li P, Guo M, Gou J, Mei M, Kong D, Li Q, Wee ATS, Fang X, Kong J, Liu Y, Wei D. Electro-Optical Multiclassification Platform for Minimizing Occasional Inaccuracy in Point-of-Care Biomarker Detection. Adv Mater 2024; 36:e2312540. [PMID: 38288781 DOI: 10.1002/adma.202312540] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/22/2023] [Revised: 01/13/2024] [Indexed: 02/06/2024]
Abstract
On-site diagnostic tests that accurately identify disease biomarkers lay the foundation for self-healthcare applications. However, these tests routinely rely on single-mode signals and suffer from insufficient accuracy, especially for multiplexed point-of-care tests (POCTs) within a few minutes. Here, this work develops a dual-mode multiclassification diagnostic platform that integrates an electrochemiluminescence sensor and a field-effect transistor sensor in a microfluidic chip. The microfluidic channel guides the testing samples to flow across electro-optical sensor units, which produce dual-mode readouts by detecting infectious biomarkers of tuberculosis (TB), human rhinovirus (HRV), and group B streptococcus (GBS). Then, machine-learning classifiers generate three-dimensional (3D) hyperplanes to diagnose different diseases. Dual-mode readouts derived from distinct mechanisms enhance the anti-interference ability physically, and machine-learning-aided diagnosis in high-dimensional space reduces the occasional inaccuracy mathematically. Clinical validation studies with 501 unprocessed samples indicate that the platform has an accuracy approaching 99%, higher than the 77%-93% accuracy of rapid point-of-care testing technologies at 100% statistical power (>150 clinical tests). Moreover, the diagnosis time is 5 min without a trade-off of accuracy. This work solves the occasional inaccuracy issue of rapid on-site diagnosis, endowing POCT systems with the same accuracy as laboratory tests and holding unique prospects for complicated scenes of personalized healthcare.
Collapse
Affiliation(s)
- Changhao Dai
- State Key Laboratory of Molecular Engineering of Polymers, Department of Macromolecular Science, Fudan University, Shanghai, 200433, China
- Laboratory of Molecular Materials and Devices, Fudan University, Shanghai, 200433, China
| | - Huiwen Xiong
- Department of Chemistry, Fudan University, Shanghai, 200433, China
| | - Rui He
- School of Nuclear Science and Technology, Lanzhou University, Lanzhou, 73000, China
- Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, 730000, China
| | - Chenxin Zhu
- Institute of Biomedical Sciences, Fudan University, Shanghai, 200032, China
| | - Pintao Li
- Department of Chemistry, Fudan University, Shanghai, 200433, China
| | - Mingquan Guo
- Department of Laboratory Medicine, Shanghai Public Health Clinical Center, Fudan University, Shanghai, 201508, China
| | - Jian Gou
- Department of Physics, National University of Singapore, Singapore, 117542, Singapore
| | - Miaomiao Mei
- Yizheng Hospital of Traditional Chinese Medicine, Yangzhou, 211400, China
| | - Derong Kong
- State Key Laboratory of Molecular Engineering of Polymers, Department of Macromolecular Science, Fudan University, Shanghai, 200433, China
- Laboratory of Molecular Materials and Devices, Fudan University, Shanghai, 200433, China
| | - Qiang Li
- Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, 730000, China
| | - Andrew Thye Shen Wee
- Department of Physics, National University of Singapore, Singapore, 117542, Singapore
| | - Xueen Fang
- Department of Chemistry, Fudan University, Shanghai, 200433, China
| | - Jilie Kong
- Department of Chemistry, Fudan University, Shanghai, 200433, China
| | - Yunqi Liu
- Laboratory of Molecular Materials and Devices, Fudan University, Shanghai, 200433, China
| | - Dacheng Wei
- State Key Laboratory of Molecular Engineering of Polymers, Department of Macromolecular Science, Fudan University, Shanghai, 200433, China
- Laboratory of Molecular Materials and Devices, Fudan University, Shanghai, 200433, China
| |
Collapse
|
3
|
Xiong H, Zhu C, Dai C, Ye X, Li Y, Li P, Yang S, Ashraf G, Wei D, Chen H, Shen H, Kong J, Fang X. An Alternating Current Electroosmotic Flow-Based Ultrasensitive Electrochemiluminescence Microfluidic System for Ultrafast Monitoring, Detection of Proteins/miRNAs in Unprocessed Samples. Adv Sci (Weinh) 2024; 11:e2307840. [PMID: 38070186 PMCID: PMC10853704 DOI: 10.1002/advs.202307840] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/18/2023] [Revised: 11/16/2023] [Indexed: 02/10/2024]
Abstract
Early diagnosis of acute diseases is restricted by the sensitivity and complex process of sample treatment. Here, an ultrasensitive, rapid, and portable electrochemiluminescence-microfluidic (ECL-M) system is described via sandwich-type immunoassay and surface plasmonic resonance (SPR) assay. Using a sandwich immunoreaction approach, the ECL-M system employs cardiac troponin-I antigen (cTnI) as a detection model with a Ru@SiO2 NPs labeled antibody as the signal probe. For miR-499-5p detection, gold nanoparticles generate SPR effects to enhance Ru(bpy)3 2+ ECL signals. The system based on alternating current (AC) electroosmotic flow achieves an LOD of 2 fg mL-1 for cTnI in 5 min and 10 aM for miRNAs in 10 min at room temperature. The point-of-care testing (POCT) device demonstrated 100% sensitivity and 98% specificity for cTnI detection in 123 clinical serum samples. For miR-499-5p, it exhibited 100% sensitivity and 97% specificity in 55 clinical serum samples. Continuous monitoring of these biomarkers in rats' saliva, urine, and interstitial fluid samples for 48 hours revealed observations rarely documented in biotic fluids. The ECL-M POCT device stands as a top-performing system for ECL analysis, offering immense potential for ultrasensitive, rapid, highly accurate, and facile detection and monitoring of acute diseases in POC settings.
Collapse
Affiliation(s)
- Huiwen Xiong
- Department of ChemistryFudan UniversityShanghai200438P. R. China
| | - Chenxin Zhu
- Institutes of Biomedical Sciences and Minhang HospitalFudan UniversityShanghai200032P. R. China
| | - Changhao Dai
- State Key Laboratory of Molecular Engineering of PolymersDepartment of Macromolecular ScienceFudan UniversityShanghai200438P. R. China
| | - Xin Ye
- Department of Laboratory MedicineThe First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anShaanxi710061P. R. China
| | - Yuanyuan Li
- Yizheng Hospital of Traditional Chinese MedicineYangzhou211400P. R. China
| | - Pintao Li
- Department of ChemistryFudan UniversityShanghai200438P. R. China
| | - Shuang Yang
- Institutes of Biomedical Sciences and Minhang HospitalFudan UniversityShanghai200032P. R. China
| | - Ghazala Ashraf
- Department of ChemistryFudan UniversityShanghai200438P. R. China
| | - Dacheng Wei
- State Key Laboratory of Molecular Engineering of PolymersDepartment of Macromolecular ScienceFudan UniversityShanghai200438P. R. China
| | - Hui Chen
- Department of ChemistryFudan UniversityShanghai200438P. R. China
| | - Huali Shen
- Institutes of Biomedical Sciences and Minhang HospitalFudan UniversityShanghai200032P. R. China
| | - Jilie Kong
- Department of ChemistryFudan UniversityShanghai200438P. R. China
| | - Xueen Fang
- Department of ChemistryFudan UniversityShanghai200438P. R. China
| |
Collapse
|
4
|
Zhang MJ, Lin L, Wang WH, Li WH, Wei CJ, Xie H, Zhang QP, Wu Y, Xiong H, Zhou SZ, Yang B, Bao XH. [Clinical and imaging features of acute encephalopathy with biphasic seizures and late reduced diffusion in children]. Zhonghua Er Ke Za Zhi 2023; 61:989-994. [PMID: 37899338 DOI: 10.3760/cma.j.cn112140-20230809-00094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 10/31/2023]
Abstract
Objective: To explore the clinical and imaging features of acute encephalopathy with biphasic seizures and late reduced diffusion(AESD) in children. Methods: For the case series study, 21 children with AESD from Peking University First Hospital, Provincial Children's Hospital Affiliated to Anhui Medical University, Children's Hospital of Fudan University, and Shanxi Children's Hospital who were diagnosed and treated from October 2021 to July 2023 were selected. Clinical data were collected to summarize their clinical information, imaging, and laboratory tests, as well as treatment and prognostic characteristics. Descriptive statistical analysis was applicated. Results: Of the 21 cases with AESD, 11 were males and 10 were females, with the age of onset of 2 years and 6 months (1 year and 7 months, 3 years and 6 months). Of the 21 cases, 18 were typical cases with biphasic seizures. All typical cases had early seizures within 24 hours before or after fever onset. Among them, 16 cases had generalized seizures, 2 cases had focal seizures, and 7 cases reached the status epilepticus. Of the 21 cases, 3 atypical cases had late seizures in biphasic only. The late seizures in the 21 cases occurred on days 3 to 9. The types of late seizures included focal seizures in 12 cases, generalized seizures in 6 cases, and both focal and generalized seizures in 3 cases. Diffusion-weighted imaging (DWI) test on days 3 to 11 showed reduced diffusion of subcortical white matter which was named "bright tree sign" in all cases. The diffuse cerebral atrophy predominantly presented in the front-parietal-temporal lobes was found in 19 cases between day 12 and 3 months after the onset of the disease. Among 21 cases, 20 had been misdiagnosed as autoimmune encephalitis, central nervous system infection, febrile convulsions, posterior reversible encephalopathy syndrome, acute disseminated encephalomyelitis, and hemiconvulsion-hemiplegia-epilepsy syndrome. All the cases received high-dose gammaglobulin and methylprednisolone pulse therapy with poor therapeutic effect. By July 2023, 18 cases were under follow-up. Among them, 17 cases were left with varying degrees of neurologic sequelae, including 11 cases with post-encephalopathic epilepsy; 1 recovered completely. Conclusions: AESD is characterized by biphasic seizures clinically and "bright tree sign" on DWI images. Symptomatic and supportive treatments are recommended. The immunotherapy is ineffective. The prognosis of AESD is poor, with a high incidence of neurological sequelae and a low mortality.
Collapse
Affiliation(s)
- M J Zhang
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - L Lin
- Department of Neurology, Provincial Children's Hospital Affiliated to Anhui Medical University, Hefei 230051, China
| | - W H Wang
- Department of Neurology, Shanxi Children's Hospital, Taiyuan 030013, China
| | - W H Li
- Department of Neurology, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai 201102, China
| | - C J Wei
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - H Xie
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - Q P Zhang
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - Y Wu
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - H Xiong
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - S Z Zhou
- Department of Neurology, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai 201102, China
| | - B Yang
- Department of Neurology, Provincial Children's Hospital Affiliated to Anhui Medical University, Hefei 230051, China
| | - X H Bao
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| |
Collapse
|
5
|
Li P, Lin Q, Xiong H, Kong J, Ye X, Fang X. Innovative Highly Specific Nucleic Acid Isothermal Detection Assay Based on the Polymerization-Coupled Endonuclease Activity of Prokaryotic DNA Polymerase I. Anal Chem 2023; 95:15755-15762. [PMID: 37824574 DOI: 10.1021/acs.analchem.3c03261] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2023]
Abstract
In this study, we developed an innovative highly specific nucleic acid isothermal detection assay based on prokaryotic DNA polymerase I with exquisitely designed fluorescent probes, achieving high sensitivity and 100% specificity within 30 min. The fluorescent nucleic acid probe was designed and constructed based on the specific flap cleavage endonuclease activity of prokaryotic DNA polymerase I (including the Bst, Bsu, Bsm, and Klenow DNA polymerases). The flap endonuclease activity depends on the length of the flap DNA and polymerization activity, which greatly reduces the false-positive rate caused by primer dimerization. This robust assay was also validated by the detection of rotavirus with great specificity and sensitivity. It could be a great alternative to qPCR in the field of point-of-care detection of pathogens.
Collapse
Affiliation(s)
- Pintao Li
- Department of Chemistry and Institute of Biomedical Sciences, Fudan University, Shanghai 200433, P. R. China
| | - Qiuyuan Lin
- Department of Chemistry and Institute of Biomedical Sciences, Fudan University, Shanghai 200433, P. R. China
| | - Huiwen Xiong
- Department of Chemistry and Institute of Biomedical Sciences, Fudan University, Shanghai 200433, P. R. China
| | - Jilie Kong
- Department of Chemistry and Institute of Biomedical Sciences, Fudan University, Shanghai 200433, P. R. China
| | - Xin Ye
- Department of Laboratory Medicine, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shaanxi P. R. China
| | - Xueen Fang
- Department of Chemistry and Institute of Biomedical Sciences, Fudan University, Shanghai 200433, P. R. China
| |
Collapse
|
6
|
Wu W, Wu W, Gong CX, Liang Y, Zhu M, Xiong H, Fu JF. [Summary of the 22 nd National Pediatric Endocrine and Genetic Metabolic Diseases Conference]. Zhonghua Er Ke Za Zhi 2023; 61:958-959. [PMID: 37803871 DOI: 10.3760/cma.j.cn112140-20230804-00077] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 10/08/2023]
Affiliation(s)
- W Wu
- Department of Endocrinology, Children's Hospital, Zhejiang University School of Medicine, Hangzhou 310052, China
| | - W Wu
- Department of Pediatrics, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, China
| | - C X Gong
- Department of Endocrinology, Genetics and Metabolism, Beijing Children's Hospital, Capital Medical University, Beijing 100045, China
| | - Y Liang
- Department of Pediatrics, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, China
| | - M Zhu
- Department of Endocrinology, Children's Hospital of Chongqing Medical University, Chongqing 400014, China
| | - H Xiong
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - J F Fu
- Department of Endocrinology, Children's Hospital, Zhejiang University School of Medicine, Hangzhou 310052, China
| |
Collapse
|
7
|
Xiong H, Li P, Cun F, Chen H, Kong J. Methylene-Blue-Encapsulated Metal-Organic-Framework-Based Electrochemical POCT Platform for Multiple Detection of Heavy Metal Ions in Milk. Biosensors (Basel) 2023; 13:783. [PMID: 37622869 PMCID: PMC10452309 DOI: 10.3390/bios13080783] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/11/2023] [Revised: 07/27/2023] [Accepted: 07/31/2023] [Indexed: 08/26/2023]
Abstract
Considering the high risk of heavy metal ions (HMIs) transferring through the food chain and accumulating in milk, a flexible and facile point-of-care testing (POCT) platform is urgently needed for the accurate, sensitive, and highly selective on-site quantification of multiple HMIs in milk. In this work, a cost-effective disk with six screen-printed electrodes (SPEs) was designed for hand-held electrochemical detection. Metal organic frameworks (MOFs) were adopted to amplify and enhance the electrochemical signals of methylene blue (MB). Using differential pulse voltammetry (DPV) methods, low limits of detection for four HMIs (Cd2+, 0.039 ppb; Hg2+, 0.039 ppb; Pb2+, 0.073 ppb; and As3+, 0.022 ppb) were achieved within four minutes. Moreover, the quantitative POCT system was applied to milk samples. The advantages of low cost, ease of on-site implementation, fast response, and accuracy allow for the POCT platform to be used in practical monitoring applications for the quantitation of multiple HMIs in milk samples.
Collapse
Affiliation(s)
| | | | | | - Hui Chen
- Department of Chemistry, Fudan University, Shanghai 200438, China
| | - Jilie Kong
- Department of Chemistry, Fudan University, Shanghai 200438, China
| |
Collapse
|
8
|
Tan DD, Liu YD, Fan YB, Wei CJ, Song DY, Yang HP, Pan H, Cui WL, Mao SS, Xu XP, Yu XL, Cui B, Xiong H. [Clinical and genetic characteristics of 9 rare cases with coexistence of dual genetic diagnoses]. Zhonghua Er Ke Za Zhi 2023; 61:345-350. [PMID: 37011981 DOI: 10.3760/cma.j.cn112140-20220922-00827] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Subscribe] [Scholar Register] [Indexed: 04/05/2023]
Abstract
Objective: To analyze the clinical and genetic characteristics of pediatric patients with dual genetic diagnoses (DGD). Methods: Clinical and genetic data of pediatric patients with DGD from January 2021 to February 2022 in Peking University First Hospital were collected and analyzed retrospectively. Results: Among the 9 children, 6 were boys and 3 were girls. The age of last visit or follow-up was 5.0 (2.7,6.8) years. The main clinical manifestations included motor retardation, mental retardation, multiple malformations, and skeletal deformity. Cases 1-4 were all all boys, showed myopathic gait, poor running and jumping, and significantly increased level of serum creatine kinase. Disease-causing variations in Duchenne muscular dystrophy (DMD) gene were confirmed by genetic testing. The 4 children were diagnosed with DMD or Becker muscular dystrophy combined with a second genetic disease, including hypertrophic osteoarthropathy, spinal muscular atrophy, fragile X syndrome, and cerebral cavernous malformations type 3, respectively. Cases 5-9 were clinically and genetically diagnosed as COL9A1 gene-related multiple epiphyseal dysplasia type 6 combined with NF1 gene-related neurofibromatosis type 1, COL6A3 gene-related Bethlem myopathy with WNT1 gene-related osteogenesis imperfecta type XV, Turner syndrome (45, X0/46, XX chimera) with TH gene-related Segawa syndrome, Chromosome 22q11.2 microduplication syndrome with DYNC1H1 gene-related autosomal dominant lower extremity-predominant spinal muscular atrophy-1, and ANKRD11 gene-related KBG syndrome combined with IRF2BPL gene-related neurodevelopmental disorder with regression, abnormal movement, language loss and epilepsy. DMD was the most common, and there were 6 autosomal dominant diseases caused by de novo heterozygous pathogenic variations. Conclusions: Pediatric patients with coexistence of double genetic diagnoses show complex phenotypes. When the clinical manifestations and progression are not fully consistent with the diagnosed rare genetic disease, a second rare genetic disease should be considered, and autosomal dominant diseases caused by de novo heterozygous pathogenic variation should be paid attention to. Trio-based whole-exome sequencing combining a variety of molecular genetic tests would be helpful for precise diagnosis.
Collapse
Affiliation(s)
- D D Tan
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - Y D Liu
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - Y B Fan
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - C J Wei
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - D Y Song
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - H P Yang
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - H Pan
- Department of Central Laboratory, Peking University First Hospital, Beijing 100034, China
| | - W L Cui
- Department of Rehabilitation, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou 450053, China
| | - S S Mao
- Department of Neurology, the Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310052, China
| | - X P Xu
- Department of Pediatrics, the First Affiliated Hospital of Harbin Medical University, Harbin 150001, China
| | - X L Yu
- Department of Neurology, Tianjin Children's Hospital, Tianjin 300134, China
| | - B Cui
- Department of Rehabilitation Medicine, Third Affiliated Hospital of Zhengzhou University, Henan Maternal and Child Health Care Hospital, Zhengzhou 450052, China
| | - H Xiong
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| |
Collapse
|
9
|
Bai Q, Chen Y, Xiao X, Chang H, Xin B, Jia L, Li J, Wang Z, Yu C, Xiong H, Zhou X. 203P MET gene copy number heterogeneity in non-small cell lung cancer patients resistant to EGFR-TKIs. J Thorac Oncol 2023. [DOI: 10.1016/s1556-0864(23)00456-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/03/2023]
|
10
|
Wu Y, Xiong H. [Early recognition, diagnosis and treatment of spinal muscular atrophy]. Zhonghua Er Ke Za Zhi 2023; 61:286-288. [PMID: 36849362 DOI: 10.3760/cma.j.cn112140-20221116-00976] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 03/01/2023]
Affiliation(s)
- Y Wu
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - H Xiong
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| |
Collapse
|
11
|
Liao KY, Liu Y, Xiong H, Chen XM, Zhang XW, Huang CL. The efficacy and safety of triplet regimens based on pomalidomide and dexamethasone for treatment of relapsed/refractory multiple myeloma: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci 2022; 26:8087-8097. [PMID: 36394758 DOI: 10.26355/eurrev_202211_30162] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]
Abstract
OBJECTIVE Triplet regimens based on pomalidomide and dexamethasone have been applied to treat relapsed/refractory multiple myeloma, but the safety and efficacy are not yet very clear. This meta-analysis aimed at comparing the safety and efficacy of different triplet therapies and analyzing the best therapy regimen. MATERIALS AND METHODS A comprehensive literature search identified a total of 615 studies, and 22 studies assessing 1,889 subjects met the inclusion criteria of this meta: phase II/III trial, over 2 median lines of prior therapy, and detailed efficacy outcomes like overall response rate (ORR), overall survival, and progression-free survival (PFS). All statistical analyses were performed by Revman version 5.3, and the heterogeneity was tested by I2 (25% indicating low heterogeneity, 50% moderate, and 75% high). For those with less heterogeneity, fixed-effect model was used. With a significant high heterogeneity, a random-effect model was used. RESULTS Pooled analysis showed ORR 66.2% across all triplet regimens based on pomalidomide and dexamethasone. Among all triplet regimens, therapy containing bortezomib showed the highest ORR (90.3%), and the one containing elotuzumab showed the lowest ORR (41.2%). The pooled ORRs for the remaining treatment regimens are as follows: cyclophosphamide (70.1%), isatuximab (66.3%), daratumumab (61.2%), clarithromycin (60.0%), pembrolizumab (47.3%). A total of 21 adverse events appeared in the included studies, with neutropenia being the highest incidence of hematologic adverse events (32.1%) and cough being the highest incidence of non-hematologic adverse events (43.3.%). CONCLUSIONS Three-drug regimens based on pomalidomide and dexamethasone could yield excellent overall response rate to relapsed/refractory multiple myeloma, but there are still various adverse events; therefore, consequent studies should address these adverse events.
Collapse
Affiliation(s)
- K-Y Liao
- Department of Hematology, Stem Cell Laboratory, Clinical Research Institute, Affiliated Hospital of Southwest Medical University, Luzhou City, Sichuan Province, China.
| | | | | | | | | | | |
Collapse
|
12
|
Li P, Xiong H, Yang B, Jiang X, Kong J, Fang X. Recent progress in CRISPR-based microfluidic assays and applications. Trends Analyt Chem 2022. [DOI: 10.1016/j.trac.2022.116812] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
13
|
Li S, Liu S, Wu Y, Liu Y, Tan D, Fan Y, Wei C, Xiong H. VP.21 Baseline nutrition investigation in a Chinese cohort of pediatric patients with spinal muscular atrophy. Neuromuscul Disord 2022. [DOI: 10.1016/j.nmd.2022.07.098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
14
|
Tan D, Zhang H, Xiong H. VP.77 Muscle transcriptomic study of a novel LAMA2-related congenital muscular dystrophy mouse model. Neuromuscul Disord 2022. [DOI: 10.1016/j.nmd.2022.07.339] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
15
|
Huang X, Yang H, Tan D, Ge L, Fan Y, Chang X, Yang Z, Xiong H. VP.78 Clinical and genetic study of LAMA2-related muscular dystrophy patients with seizures. Neuromuscul Disord 2022. [DOI: 10.1016/j.nmd.2022.07.340] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
16
|
Reck M, Barlesi F, Yang JH, Westeel V, Felip E, Özgüroğlu M, Dols MC, Sullivan R, Kowalski D, Andric Z, Lee D, Sezer A, Shamrai V, Szalai Z, Wang X, Xiong H, Jacob N, Mehr KT, Park K. OA15.03 Avelumab vs Chemotherapy for First-line Treatment of Advanced PD-L1+ NSCLC: Primary Analysis from JAVELIN Lung 100. J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.072] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
17
|
Zhou J, Lin Q, Huang Z, Xiong H, Yang B, Chen H, Kong J. Aptamer-Initiated Catalytic Hairpin Assembly Fluorescence Assay for Universal, Sensitive Exosome Detection. Anal Chem 2022; 94:5723-5728. [PMID: 35377617 DOI: 10.1021/acs.analchem.2c00231] [Citation(s) in RCA: 19] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Cancer-cell-derived exosomes are regarded as noninvasive biomarkers for early cancer diagnosis because of their critical roles in intercellular communication and molecular exchange. A robust aptamer-initiated catalytic hairpin assembly (AICHA) fluorescence assay is proposed for universal, sensitive detection of cancer-derived exosomes. The AICHA was verified with the specific detection of MCF-7 cell-derived exosomes with a wide calibration range of 8.4 particles/μL to 8.4 × 105 particles/μL and a low detection limit (LOD) of 0.5 particles/μL. The universality of the AICHA method was verified for PANC-1 cell-derived exosomes, the LOD of which was determined to be 0.1 particles/μL. The performances in serum samples were detected with a recovery rate range of 95.45-106.2%, which demonstrates its significant potential for protein biomarker analysis and cancer diagnosis.
Collapse
Affiliation(s)
- Jiaqi Zhou
- Department of Chemistry, Fudan University, Shanghai 200438, China
| | - Qiuyuan Lin
- Department of Chemistry, Fudan University, Shanghai 200438, China
| | - Zhipeng Huang
- Department of Chemistry, Fudan University, Shanghai 200438, China
| | - Huiwen Xiong
- Department of Chemistry, Fudan University, Shanghai 200438, China
| | - Bin Yang
- Department of Chemistry, Fudan University, Shanghai 200438, China
| | - Hui Chen
- Department of Chemistry, Fudan University, Shanghai 200438, China
| | - Jilie Kong
- Department of Chemistry, Fudan University, Shanghai 200438, China
| |
Collapse
|
18
|
|
19
|
Wu W, Wu W, Gong CX, Liang Y, Zhu M, Xiong H, Fu JF. [Summary of the Forum on Standardized Diagnosis,Treatment and Management of Pediatric Diseases: the 20th National Pediatric Endocrine and Genetic Metabolic Diseases Conference in 2021]. Zhonghua Er Ke Za Zhi 2022; 60:74-75. [PMID: 34986630 DOI: 10.3760/cma.j.cn112140-20211123-00981] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Affiliation(s)
- W Wu
- Department of Endocrinology, Children's Hospital,Zhejiang University School of Medicine, Hangzhou 310052, China
| | - W Wu
- Department of Pediatrics, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, China
| | - C X Gong
- Department of Endocrinology, Genetics and Metabolism, Beijing Children's Hospital, Capital Medical University, Beijing 100045, China
| | - Y Liang
- Department of Pediatrics, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, China
| | - M Zhu
- Department of Endocrinology, Children's Hospital of Chongqing Medical University, Chongqing 400014, China
| | - H Xiong
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - J F Fu
- Department of Endocrinology, Children's Hospital,Zhejiang University School of Medicine, Hangzhou 310052, China
| |
Collapse
|
20
|
Xiong H, Huang Z, Lin Q, Yang B, Yan F, Liu B, Chen H, Kong J. Surface Plasmon Coupling Electrochemiluminescence Immunosensor Based on Polymer Dots and AuNPs for Ultrasensitive Detection of Pancreatic Cancer Exosomes. Anal Chem 2021; 94:837-846. [PMID: 34914878 DOI: 10.1021/acs.analchem.1c03535] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
Polymer dots (Pdots) have become attractive electrochemiluminescence (ECL) luminophores due to their facile synthesis, easy modification, and stable electrochemical and optical properties. However, their ECL efficiency is not high enough for practical applications. In this work, we proposed an ECL immunosensor based on localized surface plasmon resonance (LSPR) between AuNPs and Pdots for the determination of pancreatic cancer exosomes. Based on the finite-difference time-domain simulations and the band energy of Pdots and AuNPs, we proposed the possible LSPR mechanism. The hot electrons of plasmonic AuNPs were photoexcited to surface plasmon states by ECL emission of Pdots, and then the excited hot electrons were transferred to the conduction band of Pdots, which significantly improved the ECL efficiency of Pdots. The ECL immunosensor displayed a wide calibration range of 1.0 × 103 to 1.0 × 106 particles/mL with a detection limit of 400 particles/mL. Cancer-related protein profiling revealed high selectivity toward different expressions of exosomal surface proteins from PANC-01, HeLa, MCF-7, and HPDE6-C7 cell lines. The proposed ECL system exhibits a promising prospect for protein biomarker profiling and early cancer-related diagnosis.
Collapse
Affiliation(s)
- Huiwen Xiong
- Department of Chemistry, Shanghai Stomatological Hospital, Fudan University, Shanghai 200438, China
| | - Zhipeng Huang
- Department of Chemistry, Shanghai Stomatological Hospital, Fudan University, Shanghai 200438, China
| | - Qiuyuan Lin
- Department of Chemistry, Shanghai Stomatological Hospital, Fudan University, Shanghai 200438, China
| | - Bin Yang
- Department of Chemistry, Shanghai Stomatological Hospital, Fudan University, Shanghai 200438, China
| | - Feng Yan
- Department of Clinical Laboratory, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, 42 Baiziting Road, Nanjing 210009, P. R. China
| | - Baohong Liu
- Department of Chemistry, Shanghai Stomatological Hospital, Fudan University, Shanghai 200438, China
| | - Hui Chen
- Department of Chemistry, Shanghai Stomatological Hospital, Fudan University, Shanghai 200438, China
| | - Jilie Kong
- Department of Chemistry, Shanghai Stomatological Hospital, Fudan University, Shanghai 200438, China
| |
Collapse
|
21
|
D'Angelo SP, Bhatia S, Brohl AS, Hamid O, Mehnert JM, Terheyden P, Shih KC, Brownell I, Lebbé C, Lewis KD, Linette GP, Milella M, Xiong H, Guezel G, Nghiem PT. Avelumab in patients with previously treated metastatic Merkel cell carcinoma (JAVELIN Merkel 200): updated overall survival data after >5 years of follow-up. ESMO Open 2021; 6:100290. [PMID: 34715570 PMCID: PMC8564559 DOI: 10.1016/j.esmoop.2021.100290] [Citation(s) in RCA: 21] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2021] [Revised: 09/29/2021] [Accepted: 10/01/2021] [Indexed: 11/03/2022] Open
Abstract
BACKGROUND Merkel cell carcinoma (MCC) is a rare, aggressive skin cancer that has a poor prognosis in patients with advanced disease. Avelumab [anti-programmed death-ligand 1 (PD-L1)] became the first approved treatment for patients with metastatic MCC (mMCC), based on efficacy and safety data observed in the JAVELIN Merkel 200 trial. We report long-term overall survival (OS) data after >5 years of follow-up from the cohort of patients with mMCC whose disease had progressed after one or more prior lines of chemotherapy. PATIENTS AND METHODS In Part A of the single-arm, open-label, phase II JAVELIN Merkel 200 trial, patients with mMCC that had progressed following one or more prior lines of chemotherapy received avelumab 10 mg/kg by intravenous infusion every 2 weeks until confirmed disease progression, unacceptable toxicity, or withdrawal. In this analysis, long-term OS was analyzed. RESULTS In total, 88 patients were treated with avelumab. At data cut-off (25 September 2020), median follow-up was 65.1 months (range 60.8-74.1 months). One patient (1.1%) remained on treatment, and an additional patient (1.1%) had reinitiated avelumab after previously discontinuing treatment. Median OS was 12.6 months [95% confidence interval (CI) 7.5-17.1 months], with a 5-year OS rate of 26% (95% CI 17% to 36%). In patients with PD-L1+ versus PD-L1- tumors, median OS was 12.9 months (95% CI 8.7-29.6 months) versus 7.3 months (95% CI 3.4-14.0 months), and the 5-year OS rate was 28% (95% CI 17% to 40%) versus 19% (95% CI 5% to 40%), respectively (HR 0.67; 95% CI 0.36-1.25). CONCLUSION Avelumab monotherapy resulted in meaningful long-term OS in patients with mMCC whose disease had progressed following chemotherapy. These results further support the role of avelumab as a standard of care for patients with mMCC.
Collapse
Affiliation(s)
- S P D'Angelo
- Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA; Department of Medicine, Weill Cornell Medical College, New York, USA.
| | - S Bhatia
- Department of Medicine, University of Washington Medical Center, Seattle, USA
| | - A S Brohl
- Sarcoma Department and Cutaneous Oncology, Moffitt Cancer Center, Tampa, USA
| | - O Hamid
- Department of Medical Oncology, The Angeles Clinic and Research Institute, a Cedars-Sinai Affiliate, Los Angeles, USA
| | - J M Mehnert
- Division of Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, USA
| | - P Terheyden
- Department of Dermatology, University of Lübeck, Lübeck, Germany
| | - K C Shih
- Department of Medical Oncology, Sarah Cannon Research Institute, Nashville, USA; Department of Medical Oncology, Tennessee Oncology, Nashville, USA
| | - I Brownell
- Dermatology Branch, National Institutes of Health, Bethesda, USA
| | - C Lebbé
- Université de Paris, INSERM U976, Paris, France; Dermatology and CIC, AP-HP, Saint Louis Hospital, Paris, France
| | - K D Lewis
- Department of Medicine, University of Colorado Denver School of Medicine, Aurora, USA
| | - G P Linette
- Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, USA
| | - M Milella
- Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust (AOUI Verona), Verona, Italy
| | - H Xiong
- Biostatistics, EMD Serono Research & Development Institute, Inc., Billerica, USA, an affiliate of Merck KGaA
| | - G Guezel
- Clinical Development, Merck Healthcare KGaA, Darmstadt, Germany
| | - P T Nghiem
- Division of Dermatology, Department of Medicine, University of Washington Medical Center at South Lake Union, Seattle, USA
| |
Collapse
|
22
|
Chen X, Dang H, Chen Q, Chen Z, Ma Y, Liu X, Lin P, Zou H, Xiong H. Endoscopic sinus surgery improves Eustachian tube function in patients with chronic rhinosinusitis: a multicenter prospective study. Rhinology 2021; 59:560-566. [PMID: 34608896 DOI: 10.4193/rhin21.209] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
BACKGROUND Patients with chronic rhinosinusitis (CRS) often have Eustachian tube dysfunction (ETD) symptoms. This study aimed to prospectively investigate the effect of endoscopic sinus surgery (ESS) on improvement of Eustachian tube function in CRS patients with ETD from a Chinese population and determine factors associated with improvement. METHODS A prospective study was performed in CRS patients with ETD who underwent ESS from 3 tertiary medical centers in south China. The Eustachian tube Dysfunction Questionnaire 7 (ETDQ-7), Sinonasal Outcome Test 22 (SNOT-22), tympanograms, endoscopic findings and Valsalva maneuver were recorded and analyzed preoperatively and postoperatively at 8-12 weeks. RESULTS A total of 70 CRS patients with ETD were included in this study. The ETDQ-7 score and the ability of positive Valsalva maneuver in CRS patients were significantly improved postoperatively at 8-12 weeks. The number of patients with type A tympanogram was increased postoperatively. Reduced Eustachian tube mucosal inflammation was also observed postoperatively. In addition, ESS appeared to reverse slight tympanic membrane atelectasis after 8-12 weeks. Moreover, improvement in tympanogram was presented in more than half of CRS patients with concomitant otitis media with effusion postoperatively at 8-12 weeks. Univariate and multivariate analysis revealed failure of normalization of ETDQ-7 postoperatively was associated with concomitant allergic rhinitis and higher preoperative SNOT-22 score. CONCLUSIONS This study confirms Eustachian tube function is often improved after ESS in CRS patients with ETD. Concomitant allergic rhinitis and higher preoperative SNOT-22 score are associated with failure of normalization of ETD symptoms.
Collapse
Affiliation(s)
- X Chen
- Department of Otolaryngology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.,Institute of Hearing and Speech-Language Science, Sun Yat-sen University, Guangzhou, Guangdong, China
| | - H Dang
- Department of Otolaryngology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
| | - Q Chen
- Department of Otolaryngology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
| | - Z Chen
- Dazhu County People's Hospital, Dazhou, Sichuan, China
| | - Y Ma
- Department of Otolaryngology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
| | - X Liu
- Department of Otolaryngology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
| | - P Lin
- Department of Otolaryngology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
| | - H Zou
- Department of Otolaryngology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
| | - H Xiong
- Department of Otolaryngology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China 2 Institute of Hearing and Speech-Language Science, Sun Yat-sen University, Guangzhou, Guangdong, China
| |
Collapse
|
23
|
Masson R, Boespflug-Tanguy O, Darras B, Day J, Deconinck N, Klein A, Mazurkiewicz-Bełdzińska M, Mercuri E, Rose K, Servais L, Vlodavets D, Xiong H, Zanoteli E, Dodman A, El-Khairi M, Gaki E, Gerber M, Gorni K, Kletzl H, Baranello G. SMA - TREATMENT. Neuromuscul Disord 2021. [DOI: 10.1016/j.nmd.2021.07.303] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
24
|
Xiong H, Huang Z, Yang Z, Lin Q, Yang B, Fang X, Liu B, Chen H, Kong J. Recent Progress in Detection and Profiling of Cancer Cell-Derived Exosomes. Small 2021; 17:e2007971. [PMID: 34075696 DOI: 10.1002/smll.202007971] [Citation(s) in RCA: 61] [Impact Index Per Article: 20.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/18/2020] [Revised: 02/23/2021] [Indexed: 05/24/2023]
Abstract
Exosomes, known as nanometer-sized vesicles (30-200 nm), are secreted by many types of cells. Cancer-derived exosomes have great potential to be biomarkers for early clinical diagnosis and evaluation of cancer therapeutic efficacy. Conventional detection methods are limited to low sensitivity and reproducibility. There are hundreds of papers published with different detection methods in recent years to address these challenges. Therefore, in this review, pioneering researches about various detection strategies are comprehensively summarized and the analytical performance of these tests is evaluated. Furthermore, the exosome molecular composition (protein and nucleic acid) profiling, a single exosome profiling, and their application in clinical cancer diagnosis are reviewed. Finally, the principles and applications of machine learning method in exosomes researches are presented.
Collapse
Affiliation(s)
- Huiwen Xiong
- Department of Chemistry, Shanghai Stomatological Hospital, Fudan University, Shanghai, 200438, P. R. China
| | - Zhipeng Huang
- Department of Chemistry, Shanghai Stomatological Hospital, Fudan University, Shanghai, 200438, P. R. China
| | - Zhejun Yang
- Department of Chemistry, Shanghai Stomatological Hospital, Fudan University, Shanghai, 200438, P. R. China
| | - Qiuyuan Lin
- Department of Chemistry, Shanghai Stomatological Hospital, Fudan University, Shanghai, 200438, P. R. China
| | - Bin Yang
- Department of Chemistry, Shanghai Stomatological Hospital, Fudan University, Shanghai, 200438, P. R. China
| | - Xueen Fang
- Department of Chemistry, Shanghai Stomatological Hospital, Fudan University, Shanghai, 200438, P. R. China
| | - Baohong Liu
- Department of Chemistry, Shanghai Stomatological Hospital, Fudan University, Shanghai, 200438, P. R. China
| | - Hui Chen
- Department of Chemistry, Shanghai Stomatological Hospital, Fudan University, Shanghai, 200438, P. R. China
| | - Jilie Kong
- Department of Chemistry, Shanghai Stomatological Hospital, Fudan University, Shanghai, 200438, P. R. China
| |
Collapse
|
25
|
Liu JZ, Li XB, Xiong H. A FPGA-based adaptive differential current source for electrical impedance tomography. Rev Sci Instrum 2021; 92:094707. [PMID: 34598505 DOI: 10.1063/5.0062640] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/07/2021] [Accepted: 08/23/2021] [Indexed: 06/13/2023]
Abstract
A high output impedance current source with a wide bandwidth is needed in electrical impedance tomography systems. Limitations appear mainly at higher frequencies and non-simple loads. In order to adjust the output current, the amplitude and phase are made to achieve the expected value automatically. A current source based on the field programmable gate array is designed. In this paper, we proposed a double DAC differential current source structure. By measuring the voltage of the sampling resistor in series with the load and using the proposed dynamic reference point demodulation algorithm, the actual current amplitude and phase on the load can be quickly obtained. Through the adaptive compensation module, the output current is adjusted to the expected value. The experimental results show that the output resistance of the current source can reach 10 MΩ and the output capacitance can be less than 0.8 pF in the frequency range of 10 kHz-1.28 MHz. At the same time, the current amplitude attenuation is less than 0.016%, and the phase error is less than 0.0025° after compensation. Therefore, the proposed current source achieves widebands, biocompatibility, and high precision.
Collapse
Affiliation(s)
- J Z Liu
- The School of Control Science and Engineering, Tiangong University, Tianjin 300387, People's Republic of China
| | - X B Li
- The School of Control Science and Engineering, Tiangong University, Tianjin 300387, People's Republic of China
| | - H Xiong
- The School of Control Science and Engineering, Tiangong University, Tianjin 300387, People's Republic of China
| |
Collapse
|
26
|
Xiong J, Yang J, Li W, Xiong H, Liu G, Wu F, Fan N, Zeng X, Huang F, Yang L, Tu X, Shi C, Yi B, Ye J, Li P, Tang C, Huang J, Hou P, Zang W, Tan S. 1411P A prospective, multicenter, real-world study of apatinib in the treatment of gastric cancer. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.1520] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
27
|
Xiong H, Huang D. 089 The mevalonate pathway enzyme HMGCS1 upregulation in keratinocytes contributes to psoriasis by promoting IL-23 expression. J Invest Dermatol 2021. [DOI: 10.1016/j.jid.2021.02.107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
28
|
Tan SF, Ni JX, Xiong H. LncRNA UNC5B-AS1 promotes malignant progression of prostate cancer by competitive binding to caspase-9. Eur Rev Med Pharmacol Sci 2021; 24:2271-2280. [PMID: 32196578 DOI: 10.26355/eurrev_202003_20493] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE This study aims to investigate the expression of LncRNA UNC5B-AS1 in prostate cancer (PCa) and to further investigate whether it can prompt malignant progression of PCa via regulating caspase-9. PATIENTS AND METHODS Quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) was conducted to examine UNC5B-AS1 expression in 50 pairs of tumor tissue specimens and paracancerous ones collected from PCa patients, and the interplay between UNC5B-AS1 expression and clinical indicators of PCa was also analyzed. Meanwhile, UNC5B-AS1 levels in PCa cell lines were also further verified by qRT-PCR. In addition, UNC5B-AS1 knockdown model was constructed using lentivirus in PCa cell lines, and cell counting kit-8 (CCK-8), 5-Ethynyl-2'-deoxyuridine (EdU), transwell and flow cytometry assays were performed to figure out the impact of UNC5B-AS1 on the biological function of PCa cells. Finally, cell recovery experiment was conducted to explore the underlying mechanism and the association between UNC5B-AS1 and caspase-9. RESULTS QRT-PCR results suggested that UNC5B-AS1 expression in PCa tissue samples was remarkably higher than in adjacent ones, with a statistically significant difference. Compared with patients with low expression of UNC5B-AS1, patients with highly-expressed UNC5B-AS1 had a higher incidence of distant metastasis and more advanced pathological stage. At the same time, proliferation and invasion, as well as migration ability of cells in sh-UNC5B-AS1 group, was conspicuously attenuated while cell apoptosis ability was conversely enhanced. Furthermore, qRT-PCR results revealed that caspase-9 and UNC5B-AS1 showed a negative correlation in gene expression level in PCa tissues. The results of the luciferase reporter gene experiment demonstrated that UNC5B-AS1 can be targeted by caspase-9 through their binding site. Additionally, cell recovery experiment indicated that UNC5B-AS1 and caspase-9 can be mutually regulated, which then together affect the malignant progression of PCa. CONCLUSIONS UNC5B-AS1 expression was found remarkably increased in both PCa tissues and cell lines, which was remarkably associated with pathological stage and incidence of distant metastasis of PCa patients. In addition, UNC5B-AS1 was able to accelerate the malignant progression of PCa by modulating caspase-9 expression.
Collapse
Affiliation(s)
- S-F Tan
- Department of Urology, Linyi People's Hospital, Linyi, China.
| | | | | |
Collapse
|
29
|
Wang L, Xi D, Xiong H, Memon S, Li G, Gu Z, Nadir S, Deng W. Microsatellite markers reveal polymorphisms at the 3′ untranslated region of the SLC11A1 gene in Zhongdian Yellow cattle ( Bos taurus). Can J Anim Sci 2021. [DOI: 10.1139/cjas-2018-0231] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Solute carrier family 11-member A1 (SLC11A1) gene encodes natural macrophage resistance-associated protein which regulates activity of macrophages against intracellular pathogens. The objective of this study was to study the polymorphism in the microsatellites present at 3′ untranslated region (UTR) of the SLC11A1 gene in 113 Zhongdian Yellow cattle (Bos taurus). Using DNA bi-directional sequencing, we detected seven alleles (GT10–16) for the first microsatellite (MS1), five alleles (GT12–16) for MS2, and four alleles (GT4–7) for MS3. MS3 is studied for the first time and revealed four novel variants (alleles GT4–7). Alleles GT12 (45.1%), GT13 (59.3%), and GT5 (85.4%) were the most frequent alleles at MS1, MS2, and MS3, respectively, Genotypes G12/12, G13/13, and G5/5 had the highest frequency 0.239, 0.540, and 0.743 at MS1, MS2, and MS3, respectively. Haplotypic data revealed that GT12/GT13 was the most frequent haplotype observed followed by GT12/14 haplotype. Three nucleotide variations were observed in MS1 and MS2. Comparative analysis of GT12/GT12 and GT13/GT13 genotype with other bovine genotypes showed significant difference (P > 0.05). Our results suggest that the homozygous genotypes GT12/GT12 and GT13/GT13 in Zhongdian Yellow cattle might be related to disease resistance. The findings reported in this study would be helpful in cattle breeding programs.
Collapse
Affiliation(s)
- L. Wang
- Yunnan Provincial Key Laboratory of Animal Nutrition and Feed, Faculty of Animal Science and Technology, Yunnan Agricultural University, Kunming, People’s Republic of China
- Department of Life Science and Technology, Xinxiang University, Xinxiang 453003, People’s Republic of China
| | - D. Xi
- Yunnan Provincial Key Laboratory of Animal Nutrition and Feed, Faculty of Animal Science and Technology, Yunnan Agricultural University, Kunming, People’s Republic of China
| | - H. Xiong
- Yunnan Provincial Key Laboratory of Animal Nutrition and Feed, Faculty of Animal Science and Technology, Yunnan Agricultural University, Kunming, People’s Republic of China
- Yunnan Animal Science and Veterinary Institute, Kunming 650224, People’s Republic of China
| | - S. Memon
- Yunnan Provincial Key Laboratory of Animal Nutrition and Feed, Faculty of Animal Science and Technology, Yunnan Agricultural University, Kunming, People’s Republic of China
- Yunnan Animal Science and Veterinary Institute, Kunming 650224, People’s Republic of China
| | - G. Li
- Yunnan Provincial Key Laboratory of Animal Nutrition and Feed, Faculty of Animal Science and Technology, Yunnan Agricultural University, Kunming, People’s Republic of China
| | - Z. Gu
- Yunnan Provincial Key Laboratory of Animal Nutrition and Feed, Faculty of Animal Science and Technology, Yunnan Agricultural University, Kunming, People’s Republic of China
| | - S. Nadir
- University of Science and Technology Bannu, Bannu 28100, Pakistan
| | - W. Deng
- Yunnan Provincial Key Laboratory of Animal Nutrition and Feed, Faculty of Animal Science and Technology, Yunnan Agricultural University, Kunming, People’s Republic of China
| |
Collapse
|
30
|
Xiong H, Ye X, Li Y, Qi J, Fang X, Kong J. Efficient Microfluidic-Based Air Sampling/Monitoring Platform for Detection of Aerosol SARS-CoV-2 On-site. Anal Chem 2021; 93:4270-4276. [PMID: 33635067 DOI: 10.1021/acs.analchem.0c05154] [Citation(s) in RCA: 30] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
Airborne pathogens have been considered as highly infectious and transmittable between humans. With the pandemic outbreak of the coronavirus disease 2019 (COVID-19), an on-site diagnostic system-integrated airborne pathogen-monitoring machine is recommended by experts for preventing and controlling the early stage β-coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread. In this work, a small-volume rotating microfluidic fluorescence chip-integrated aerosol SARS-CoV-2 sampling system was constructed to satisfy the demand for rapid on-site sample collection and detection of SARS-CoV-2. The rotating microfluidic fluorescence system with small volume has very high sensitivity in the detection of SARS-CoV-2 (detection limit of 10 copies/μL with the shortest Ct value of 15 min), which is comparable to reverse transcription polymerase chain reaction (RT-PCR). The precision variation coefficients within/between batches are very low [coefficient of variation (CV) % ≤ 5.0%]. Our work has passed the comprehensive inspection of the microfluidic chip performance by the Shanghai Medical Device Testing Institute [National Medical Inspection (Design) no. 4408] and successfully tested 115 clinical samples. The integrated system exhibits 100% specificity, high sensitivity (10 copies/μL), and good precision (CV % ≤ 5.0%) in the rapid detection of SARS-CoV-2, thus realizing rapid monitoring and diagnostics of SARS-CoV-2 nucleic acid on-site.
Collapse
Affiliation(s)
- Huiwen Xiong
- Department of Chemistry and Institutes of Biomedical Sciences, Fudan University, Shanghai 200433, P. R. China
| | - Xin Ye
- Department of Chemistry and Institutes of Biomedical Sciences, Fudan University, Shanghai 200433, P. R. China
| | - Yang Li
- Shanghai Suxin Biotechnology Co. Ltd, and IgeneTec Diagnostic Products Co. Ltd., Shanghai 201318, P. R. China
| | - Jun Qi
- Tianjin Customs District, Tianjin 300022, P. R. China
| | - Xueen Fang
- Department of Chemistry and Institutes of Biomedical Sciences, Fudan University, Shanghai 200433, P. R. China
| | - Jilie Kong
- Department of Chemistry and Institutes of Biomedical Sciences, Fudan University, Shanghai 200433, P. R. China
| |
Collapse
|
31
|
Du Y, Li WP, Xiong H, Zhang S, Zhou ZY, Deng JP, Zhang JN. [Efficacy and safety of pylorus-preserving gastrectomy for early gastric cancer located in the middle third of the stomach: a meta-analysis]. Zhonghua Wei Chang Wai Ke Za Zhi 2020; 23:1088-1096. [PMID: 33212558 DOI: 10.3760/cma.j.cn.441530-20200228-00098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: It is yet to be clarified whether pylorus-preserving gastrectomy (PPG) for early gastric cancer will bring the risk of radical tumor resection, whether it will increase the incidence of postoperative complications, and how much is the benefit of the quality of life for patients after surgery, these issues are not clear. This meta-analysis aims to evaluate the efficacy and safety of pylorus-preserving gastrectomy (PPG) for early middle gastric cancer. Methods: The Chinese and English literatures about PPG and distal gastrectomy (DG) for early gastric cancer were searched from PubMed, Embase, The Cochrane Library, Web of Science, CNKI net and Wanfang database. Literature inclusion criteria: (1) Prospective or retrospective cohort study of PPG and DG for early middle-third gastric cancer published publicly; (2) Patients with early middle-third gastric cancer; (3) The enrolled literatures include at least one of the following outcome indicators: the efficacy indicators include gallstone, residual gastritis, bile reflux, delayed gastric emptying, dumping syndrome, reflux esophagitis and overall complication; the long-term prognostic indicators include 5-year survival rate and 5-year tumor recurrence. Literature exclusion criteria: (1) Reviews, case reports, conference summaries and other non-control studies; (2) Repeated published studies, incomplete studies and unextractable studies; (3) The depth of tumor invasion exceeding submucosa. The search time ended in July 2020. The basic information and evaluation indicators included in the article were extracted. The retrospective study was evaluated using Newcastle-Ottawa literature quality evaluation scale. The prospective randomized controlled study was evaluated using Jadad modified scale. Meta-analysis was performed using Review Manager 5.3. Publication bias was assessed using funnel map. Publication bias was tested using Egger tools. Results: A total of 717 literatures were retrieved, and 17 literatures were enrolled finally, including 2 randomized controlled trials and 15 retrospective studies. A total of 2427 patients were enrolled, including 948 in PPG group and 1479 in DG group. The meta-analysis of the efficacy indicators showed that there were significant differences in gallstones incidence (OR=0.42, 95% CI: 0.28-0.65, P<0.001), residual gastritis incidence (OR=0.50, 95% CI: 0.32-0.77,P=0.002), bile reflux incidence (OR=0.30, 95% CI: 0.20-0.45, P<0.001), delayed gastric emptying incidence (OR=2.40, 95% CI:1.67-3.45, P<0.001), and postoperative dumping syndrome incidence (OR=0.28, 95% CI: 0.15-0.51, P<0.001), while there were no significant differences in postoperative overall complications (OR=0.97, 95% CI: 0.69-1.35, P=0.840), reflux esophagitis incidence (OR=0.79, 95% CI: 0.39-1.61, P=0.520) between the two groups. The meta-analysis of the long-term prognostic indicators showed that no significant differences of 5-year survival (OR=1.02, 95% CI: 0.61-1.71, P=0.940) or 5-year tumor recurrence (OR=0.77, 95% CI: 0.36-1.68, P=0.520) were observed between the two groups. Conclusion: The incidences of gallstone, residual gastritis, dumping syndrome, bile reflux are lower after PPG in early gastric cancer, while the postoperative overall complications and long-term survival are comparable between PPG and DG, indicating that PPG is quite safe and feasible.
Collapse
Affiliation(s)
- Y Du
- Department of Gastrointestinal Surgery, the First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China
| | - W P Li
- Department of Gastrointestinal Surgery, Taicang Hospital Affiliated of Soochow University (the First People's Hospital of Taicang), Taicang, Jiangsu 215400, China
| | - H Xiong
- Department of Gastrointestinal Surgery, the First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China
| | - S Zhang
- Department of Gastrointestinal Surgery, the First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China
| | - Z Y Zhou
- Department of Gastrointestinal Surgery, the First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China
| | - J P Deng
- Department of Gastrointestinal Surgery, the First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China
| | - J N Zhang
- Department of Gastrointestinal Surgery, the First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China
| |
Collapse
|
32
|
Wu W, Wu W, Gong CX, Liang Y, Zhu M, Xiong H, Fu JF. [Summary of the 19th National Pediatric Endocrine and Genetic Metabolic Diseases Conference in 2020]. Zhonghua Er Ke Za Zhi 2020; 58:1038-1040. [PMID: 33256332 DOI: 10.3760/cma.j.cn112140-20200930-00912] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Affiliation(s)
- W Wu
- Department of Endocrinology, the Children's Hospital of Zhejiang University School of Medicine, Hangzhou 310052, China
| | - W Wu
- Department of Pediatrics, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
| | - C X Gong
- Department of Endocrinology, Genetics and Metabolism, Beijing Children's Hospital, Capital Medical University, Beijing 100045, China
| | - Y Liang
- Department of Pediatrics, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
| | - M Zhu
- Department of Endocrinology, Children's Hospital of Chongqing University, Chongqing 400014, China
| | - H Xiong
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - J F Fu
- Department of Endocrinology, the Children's Hospital of Zhejiang University School of Medicine, Hangzhou 310052, China
| |
Collapse
|
33
|
Xiong H, Ye X, Li Y, Wang L, Zhang J, Fang X, Kong J. Rapid Differential Diagnosis of Seven Human Respiratory Coronaviruses Based on Centrifugal Microfluidic Nucleic Acid Assay. Anal Chem 2020; 92:14297-14302. [PMID: 33073982 PMCID: PMC7586455 DOI: 10.1021/acs.analchem.0c03364] [Citation(s) in RCA: 23] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2020] [Accepted: 10/12/2020] [Indexed: 12/24/2022]
Abstract
With the global outbreak of the coronavirus disease 2019 (COVID-19), the highly infective, highly pathogenic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has attracted great attention. Currently, a method to simultaneously diagnose the seven known types human coronaviruses remains lacking and is urgently needed. In this work, we successfully developed a portable microfluidic system for the rapid, accurate, and simultaneous detection of SARS-CoV, middle east respiratory syndrome coronavirus (MERS-CoV), SARS-CoV-2, and four other human coronaviruses (HCoVs) including HCoV-229E, HCoV-OC43, HCoV-NL63, and HCoV-HKU1. The disk-like microfluidic platform integrated with loop-mediated isothermal amplification provides highly accurate, sensitive, and specific results with a wide linear range within 40 min. The diagnostic tool achieved 100% consistency with the "gold standard" polymerase chain reaction in detecting 54 real clinical samples. The integrated system, with its simplicity, is urgently needed for the diagnosis of SARS-CoV-2 during the COVID-19 pandemic.
Collapse
Affiliation(s)
- Huiwen Xiong
- Department of Chemistry and Institutes
of Biomedical Sciences, Fudan University,
Shanghai 200433, P. R. China
| | - Xin Ye
- Department of Chemistry and Institutes
of Biomedical Sciences, Fudan University,
Shanghai 200433, P. R. China
| | - Yang Li
- Shanghai Suxin
Biotechnology Co. Ltd. and IgeneTec Diagnostic Products Co.
Ltd. Shanghai 201318, P. R.
China
| | - Lijuan Wang
- Shanghai Suxin
Biotechnology Co. Ltd. and IgeneTec Diagnostic Products Co.
Ltd. Shanghai 201318, P. R.
China
| | - Jin Zhang
- Qingdao International Travel
Healthcare Center, Qingdao Customs, Qingdao
266071, P. R. China
| | - Xueen Fang
- Department of Chemistry and Institutes
of Biomedical Sciences, Fudan University,
Shanghai 200433, P. R. China
| | - Jilie Kong
- Department of Chemistry and Institutes
of Biomedical Sciences, Fudan University,
Shanghai 200433, P. R. China
| |
Collapse
|
34
|
Kang LL, Liu YP, Shen M, Chen ZH, Song JQ, He RX, Liu Y, Zhang Y, Dong H, Li MQ, Jin Y, Zheng H, Wang Q, Ding Y, Li XY, Li DX, Li HX, Liu XQ, Xiao HJ, Jiang YW, Xiong H, Zhang CY, Wang ZX, Yuan Y, Liang DS, Tian YP, Yang YL. [The phenotypes and genotypes in 314 patients with isolated methylmalonic acidemia]. Zhonghua Er Ke Za Zhi 2020; 58:468-475. [PMID: 32521958 DOI: 10.3760/cma.j.cn112140-20200401-00339] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objectives: To summarize the clinical and genetic characteristics of the patients with isolated methylmalonic acidemia and investigate the strategies for the diagnosis, treatment and prevention. Methods: Three hundred and fourteen patients (180 males, 134 females) with isolated methylmalonic acidemia were ascertained from 26 provinces or cities across the mainland of China during January 1998 to March 2020. Genetic analysis was performed by Sanger sequencing, gene panel sequencing, whole exome sequencing, multiplex ligation-dependent probe amplification or quantitative PCR. According to the age of onset, the patients were divided to early-onset group (≤12 months of age) and the late-onset group (>12 months of age). They were treated by cobalamin, L-carnitine and (or) special diet and symptomatic treatment. Statistical analysis was done using Chi-square test. Results: Fifty-eight of 314 (18.5%) patients were detected by Newborn screening using liquid chromatography tandem mass spectrometry. Five cases (1.6%) had a postmortem diagnosis. Two hundred and fifty-one patients (79.9%) were clinically diagnosed with an age of onset ranged from 3 hours after birth to 18 years. One hundred and fifty-nine patients (71.0%) belonged to early-onset groups, 65 patients (29.0%) belonged to the late-onset group. The most common symptoms were metabolic crises, psychomotor retardation, epilepsy, anemia and multiple organ damage. Metabolic acidosis and anemia were more common in early-onset patients than that in late-onset patients (20.8%(33/159) vs. 9.2% (6/65), 34.6% (55/159) vs. 16.9% (11/165), χ(2)=4.261, 6.930, P=0.039, 0.008). Genetic tests were performed for 236 patients (75.2%), 96.2%(227/236) had molecular confirmation. One hundred and twenty-seven variants were identified in seven genes (MMUT, MMAA, MMAB, MMADHC, SUCLG1, SUCLA2, and MCEE), of which 49 were novel. The mut type, caused by the deficiency of methylmalonyl-CoA mutase, was the most common (n=211, 93%) cause of this condition. c.729_730insTT, c.1106G>A and c.914T>C were the three most frequent mutations in MMUT gene. The frequency of c.914T>C in early-onset patients was significantly higher than that in late-onset patients (8.3% (18/216) vs. 1.6% (1/64), χ(2)=3.859, P=0.037). Metabolic crisis was more frequent in mut type than the other types (72.6% (114/157) vs. 3/13, χ(2)=13.729, P=0.001),developmental delay and hypotonia were less frequent in mut type (38.2% (60/157) vs. 9/13, 25.5% (40/157) vs. 8/13, χ(2)=4.789, 7.705, P=0.030, 0.006). Of the 58 patients identified by newborn screening, 44 patients (75.9%) who were treated from asymptomatic phase developed normally whereas 14 patients (24.1%) who received treatment after developing symptoms exhibited varying degrees of psychomotor retardation. Conclusions: The characteristics of phenotypes and genotypes among Chinese patients with isolated methylmalonic acidemia were analyzed. Expanded the mutation spectrum of the associated genes. Because of the complex clinical manifestations and severe early onset of isolated methylmalonic acidemia, Newborn screening is crucial for early diagnosis and improvement of prognosis. MMUT gene is recommended for carrier screening as an effort to move the test earlier as a part of the primary prevention of birth defects.
Collapse
Affiliation(s)
- L L Kang
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - Y P Liu
- Department of Pediatrics, Peking University People's Hospital, Beijing 100044, China
| | - M Shen
- Translational Medicine Laboratory, Chinese People's Liberation Army General Hospital, Beijing 100045, China
| | - Z H Chen
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - J Q Song
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - R X He
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - Y Liu
- Clinical Laboratory, China-Japan Friendship Hospital, Beijing 100029, China
| | - Y Zhang
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - H Dong
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - M Q Li
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - Y Jin
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - H Zheng
- Department of Pediatrics, First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou 450000, China
| | - Q Wang
- Department of Endocrinology and Genetic Beijing Children's Hospital, Capital Medical University, Beijing 100045, China
| | - Y Ding
- Department of Endocrinology and Genetic Beijing Children's Hospital, Capital Medical University, Beijing 100045, China
| | - X Y Li
- Precision Medicine Center, General Hospital of Tianjin Medical University, Tianjin 300020, China
| | - D X Li
- Department of Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou 450003, China
| | - H X Li
- Clinical Laboratory, Peking University First Hospital, Beijing 100034, China
| | - X Q Liu
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - H J Xiao
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - Y W Jiang
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - H Xiong
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - C Y Zhang
- Translational Medicine Laboratory, Chinese People's Liberation Army General Hospital, Beijing 100045, China
| | - Z X Wang
- Department of Neurology, Peking University First Hospital, Beijing 100034, China
| | - Y Yuan
- Department of Neurology, Peking University First Hospital, Beijing 100034, China
| | - D S Liang
- Center for Medical Genetics, School of Life Sciences, Central South University, Changsha 430074, China
| | - Y P Tian
- Translational Medicine Laboratory, Chinese People's Liberation Army General Hospital, Beijing 100045, China
| | - Y L Yang
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| |
Collapse
|
35
|
Fan YB, Zhang H, Xiong H. [Recent advances in LMNA gene related muscular dystrophy]. Zhonghua Er Ke Za Zhi 2020; 58:512-515. [PMID: 32521967 DOI: 10.3760/cma.j.cn112140-20200313-00228] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Affiliation(s)
- Y B Fan
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - H Zhang
- Institute of Cardiovascular Sciences and Key Laboratory of Molecular Cardiovascular Sciences, Peking University Health Science Center, Beijing 100191, China
| | - H Xiong
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| |
Collapse
|
36
|
Chen XY, Chang XZ, Fu XN, Ge L, Fan YB, Liu JY, Wang ZQ, Zhang W, Xiong H. [Clinical phenotype and genotype of early-onset facioscapulohumeral muscular dystrophy type 1]. Zhonghua Er Ke Za Zhi 2020; 58:408-412. [PMID: 32392958 DOI: 10.3760/cma.j.cn112140-20191015-00648] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To explore the clinical, pathological and genetic characteristics of early-onset facioscapulohumeral muscular dystrophy type 1 (FSHD1), in order to increase awareness of the disease. Methods: In this retrospective study, the history of 3 patients, who were diagnosed with early-onset FSHD1 by molecular genetic test in Pediatric Outpatient Department of Peking University First Hospital from 4(th) June 2012 to 4(th) June 2018, were collected. Their clinical data, genotypes, phenotypes and pathological features of muscle biopsy were analyzed. Results: All the three patients were males at the age of 14 years, 11 years and 9 years 11 months, respectively, whose onset age was between infancy and early childhood and they got confirmed diagnosis within 4 to 10 years after the onset of illness. Their molecular genetic testing indicated that the number of D4Z4 repeat arrays located in 4qA were 2, 3 and 4, which was consistent with the characteristics of early-onset FSHD1. Their common clinical manifestations were facial, scapular and proximal lower limb muscle progressively and asymmetrically weakness. All patients had different severity of spine deformity and high-frequency dominant sensorineural hearing loss, however, the phenotype of the third patient with 4 D4Z4 repeats was significantly the most severe. Conclusions: Early-onset FSHD1 usually concealed onset and is difficult to diagnose. Its precise diagnosis depends on molecular genetic techniques, but the genotypes of 3 patients here are not corresponding to phenotypes strictly and it is necessary to accumulate more cases for further analysis in order to provide a more reliable basis for the relationship of genotype-phenotype and prognosis evaluation of the disease.
Collapse
Affiliation(s)
- X Y Chen
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - X Z Chang
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - X N Fu
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - L Ge
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - Y B Fan
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - J Y Liu
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - Z Q Wang
- Department of Neurology and Institute of Neurology, First Affiliated Hospital, Fujian Medical University, Fuzhou 350005, China
| | - W Zhang
- Department of Human and Molecular Genetics, Baylor College of Medicine, Houston 75800, USA
| | - H Xiong
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| |
Collapse
|
37
|
Chen Z, Xiong H, Li JX, Li H, Tao F, Yang YT, Wu B, Tang W, Teng JX, Fu Q, Yang L. [COVID-19 with post-chemotherapy agranulocytosis in childhood acute leukemia: a case report]. Zhonghua Xue Ye Xue Za Zhi 2020; 41:341-343. [PMID: 32149486 PMCID: PMC7364917 DOI: 10.3760/cma.j.issn.0253-2727.2020.0004] [Citation(s) in RCA: 27] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/19/2020] [Indexed: 12/15/2022]
Affiliation(s)
- Z Chen
- Department of Hematology and Oncology, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430016, China
| | - H Xiong
- Department of Hematology and Oncology, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430016, China
| | - J X Li
- Department of Hematology and Oncology, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430016, China
| | - H Li
- Department of Hematology and Oncology, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430016, China
| | - F Tao
- Department of Hematology and Oncology, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430016, China
| | - Y T Yang
- Department of Hematology and Oncology, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430016, China
| | - B Wu
- Department of Hematology and Oncology, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430016, China
| | - W Tang
- Department of Hematology and Oncology, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430016, China
| | - J X Teng
- Department of Hematology and Oncology, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430016, China
| | - Q Fu
- Department of Hematology and Oncology, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430016, China
| | - L Yang
- Department of Hematology and Oncology, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430016, China
| |
Collapse
|
38
|
Wei CJ, Wang ZX, Chang XZ, Lyu JL, Ge L, Fan YB, Zhang YH, Xiong H. [Childhood reducing body myopathy caused by FHL1 gene variation in a child]. Zhonghua Er Ke Za Zhi 2020; 58:147-149. [PMID: 32102154 DOI: 10.3760/cma.j.issn.0578-1310.2020.02.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- C J Wei
- Department of Pediatrics, Peking University First Hospital, Beijing100034, China
| | - Z X Wang
- Department of Neurology, Peking University First Hospital, Beijing 100034, China
| | - X Z Chang
- Department of Pediatrics, Peking University First Hospital, Beijing100034, China
| | - J L Lyu
- Department of Neurology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China
| | - L Ge
- Department of Pediatrics, Peking University First Hospital, Beijing100034, China
| | - Y B Fan
- Department of Pediatrics, Peking University First Hospital, Beijing100034, China
| | - Y H Zhang
- Department of Pediatrics, Peking University First Hospital, Beijing100034, China
| | - H Xiong
- Department of Pediatrics, Peking University First Hospital, Beijing100034, China
| |
Collapse
|
39
|
Yu JY, Zhang D, Huang XL, Ma J, Yang C, Li XJ, Xiong H, Zhou B, Liao RK, Tang ZY. Quantitative Analysis of DCE-MRI and RESOLVE-DWI for Differentiating Nasopharyngeal Carcinoma from Nasopharyngeal Lymphoid Hyperplasia. J Med Syst 2020; 44:75. [PMID: 32103352 DOI: 10.1007/s10916-020-01549-y] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2019] [Accepted: 02/18/2020] [Indexed: 02/08/2023]
Abstract
To explore the ability of quantitative dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) analysis and readout segmentation of long variable echo-trains diffusion weighted imaging (RESOLVE-DWI) to distinguish nasopharyngeal carcinoma (NPC) from nasopharyngeal lymphoid hyperplasia (NPLH). Twenty-five patients with NPC and 30 patients with NPLH were evaluated. Three quantitative DCE-MRI parameters (Ktrans, Kep and Ve) and the apparent diffusion coeffcient (ADC) of lesions were calculated. The two independent samples t test or Mann-Whitney U test was used to compare the parameters between NPC and NPLH group. Receiver operating characteristic (ROC) curve analysis was used to assess the diagnostic ability for distinguishing NPC from NPLH. A P value less than 0.05 was considered statistically significant. The difference in Ktrans value between the NPC group and the NPLH group was statistically significant, and the value of the NPC group was larger than that of the NPLH group. There was no statistical difference in Kep and Ve between the two groups. The ADC value of NPC group was smaller than that of NPLH group, and the difference was statistically significant. ROC curve analysis showed that both Ktrans and ADC were effective in diagnosing NPC and the area under the curve (AUC) was 0.773 and 0.704, respectively. In addition, the combination of Ktrans and ADC demonstrated the obviously improved AUC of 0.884. DCE-MRI and RESOLVE-DWI are effective in differentiating NPC from NPLH, especially the combination of the two models.
Collapse
Affiliation(s)
- J Y Yu
- Department of Radiology, Chongqing General Hospital, University of Chinese Academy of Sciences, No.104 Pipashan Rd, Yuzhong District, Chongqing, 400014, China
| | - D Zhang
- Department of Radiology, Chongqing General Hospital, University of Chinese Academy of Sciences, No.104 Pipashan Rd, Yuzhong District, Chongqing, 400014, China
| | - X L Huang
- Department of Radiology, Chongqing General Hospital, University of Chinese Academy of Sciences, No.104 Pipashan Rd, Yuzhong District, Chongqing, 400014, China
| | - J Ma
- Department of Radiology, Chongqing General Hospital, University of Chinese Academy of Sciences, No.104 Pipashan Rd, Yuzhong District, Chongqing, 400014, China
| | - C Yang
- Department of Radiology, Chongqing General Hospital, University of Chinese Academy of Sciences, No.104 Pipashan Rd, Yuzhong District, Chongqing, 400014, China
| | - X J Li
- Department of Radiology, Chongqing General Hospital, University of Chinese Academy of Sciences, No.104 Pipashan Rd, Yuzhong District, Chongqing, 400014, China
| | - H Xiong
- Department of Radiology, Chongqing General Hospital, University of Chinese Academy of Sciences, No.104 Pipashan Rd, Yuzhong District, Chongqing, 400014, China
| | - B Zhou
- Department of Radiology, Chongqing General Hospital, University of Chinese Academy of Sciences, No.104 Pipashan Rd, Yuzhong District, Chongqing, 400014, China
| | - R K Liao
- Department of Radiology, Chongqing General Hospital, University of Chinese Academy of Sciences, No.104 Pipashan Rd, Yuzhong District, Chongqing, 400014, China
| | - Z Y Tang
- Department of Radiology, Chongqing General Hospital, University of Chinese Academy of Sciences, No.104 Pipashan Rd, Yuzhong District, Chongqing, 400014, China. .,Molecular and Functional Imaging Laboratory, Chongqing General Hospital, University of Chinese Academy of Sciences, Chongqing, 400014, China.
| |
Collapse
|
40
|
Liu S, Wang CL, Wang HB, Liu C, Li XY, Xiong H. [Meta-analysis on tetanus antibody protection rate of healthy population born after 1978 in China]. Zhonghua Yu Fang Yi Xue Za Zhi 2020; 54:203-208. [PMID: 32074711 DOI: 10.3760/cma.j.issn.0253-9624.2020.02.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: Meta-analysis was conducted on the tetanus antibody protection rate of healthy population born after 1978 in China (data from Hong Kong, Macao and Taiwan was excluded, the same below). Methods: Search the data on China's tetanus antibody level which were published in China National Knowledge Infrastructure, Wanfang data, VIP, SinoMed database, PubMed and the Cochrane Library. The Chinese search keywords were "Tetanus Antitoxin", "Tetanus Antibody", "Healthy Population" and "Mainland China". English search terms include "tetanus antitoxin", "tetanus vaccine", "tetanus vaccine", "general population" and "mainland of China". The time limit for inclusion in literature research was 2010-2019. Stata software was used to conduct meta-analysis on the protection rate of tetanus antibody. Results: A total of 24 articles were included. There was no obvious publication bias in the included articles. The total number of respondents was 23 530, the antibody protection rate was 49.5%-99.0%. A total of 20 817 people got effective antibody protection, which meant the antibody level reached and exceeded 0.1 IU/ml, and the combined protection rate was 78.6% (95%CI: 75.0%-88.2%). The combined protection rates of antibody in 0-7 years old and 8-15 years old groups were 88.9% (95%CI: 86.9%-91.0%) and 79.3% (95%CI: 72.9%-86.2%) respectively. The combined protection rates of antibodies in 16-20 years old, 21-30 years old and 31-40 years old groups were 58.9% (95%CI: 46.5%-71.2%), 47.7% (95%CI: 16.8%-78.7%) and 63.8% (95%CI:32.6%-95.1%) respectively. The combined protection rate of tetanus antibody for 0-15 years old people was 85.6% (95%CI: 83.1%-88.1%), and the combined protection rate of antibody for 16-40 years old people was 52.9% (95%CI: 39.3%-66.6%). Conclusion: With the increase of age, the protection rate of tetanus antibody among the healthy population aged 16-40 years in our country decreases. An individualized vaccination plan should be formulated according to the previous tetanus vaccination history and the tetanus antibody level when necessary.
Collapse
Affiliation(s)
- S Liu
- Department of Emergency, Peking University First Hospital, Beijing 100034, China
| | - C L Wang
- Emergency Department/Trauma Center, Peking University People's Hospital, Beijing 100044, China
| | - H B Wang
- Department of Emergency, Peking University First Hospital, Beijing 100034, China
| | - C Liu
- Department of Emergency, Peking University First Hospital, Beijing 100034, China
| | - X Y Li
- Department of Medical Statistics, Peking University First Hospital, Beijing 100034, China
| | - H Xiong
- Department of Emergency, Peking University First Hospital, Beijing 100034, China
| |
Collapse
|
41
|
Han YH, Wan Y, Xiong H, Sun GL. Structural maintenance of chromosomes 2 is identified as an oncogene in bladder cancer in vitro and in vivo. Neoplasma 2020; 67:364-370. [PMID: 31986889 DOI: 10.4149/neo_2020_190510n419] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2019] [Accepted: 08/26/2019] [Indexed: 11/08/2022]
Abstract
Taurine upregulated gene 1 (TUG1) has been found to promote bladder cancer cell growth in our recent research. In this study, TUG1-depleted bladder cancer cells were used to identify potent players in bladder cancer. Human gene expression arrays were used for transcriptome profiling of TUG1-depleted bladder cancer cells. Cell proliferation was analyzed by MTT assay. Cell apoptosis and cell cycle were analyzed by flow cytometry. Colony formation assay was used to observe the changes of colony formation rates. Xenograft formation assay was performed in nude mice. Immunohistochemical staining was used to test the gene expression levels in tissues from bladder cancer patients. We found that deregulated genes were strongly enriched in cell cycle or pathways in cancer in TUG1-depleted bladder cancer cells. Structural maintenance of chromosomes 2 (SMC2) was inhibited after TUG1 knockdown. The depletion of TUG1 or SMC2 led to G2/M phase arrest in bladder cancer cells. SMC2 depletion inhibited bladder cancer cell proliferation, promoted apoptosis, decreased colony formation, and reduced tumor growth in xenograft nude mice. Overexpression of SMC2 restored the growth of TUG1-depleted cells. The expression levels of SMC2 were higher in human bladder cancer tissues than that in paired normal tissues. Our data suggest that SMC2 is an oncogene in bladder cancer and depletion of SMC2 might have potential therapeutical significance in bladder cancer.
Collapse
Affiliation(s)
- Y H Han
- Department of Clinical Medicine, Tibet University Medical College, Lhasa, China
| | - Y Wan
- Department of Geriatric Medicine and Neurology, West China School of Public Health and West China Forth Hospital, Sichuan University, Chengdu, China
| | - H Xiong
- Department of Clinical Medicine, Tibet University Medical College, Lhasa, China.,Department of Geriatric Medicine and Neurology, West China School of Public Health and West China Forth Hospital, Sichuan University, Chengdu, China
| | - G L Sun
- Department of Clinical Medicine, Tibet University Medical College, Lhasa, China
| |
Collapse
|
42
|
Wu W, Wu W, Gong CX, Liang Y, Zhu M, Xiong H, Luo XP, Fu JF. [Summary of the 18(th) National Conference on Pediatric Endocrine and Genetic Metabolic Diseases]. Zhonghua Er Ke Za Zhi 2019; 57:982-983. [PMID: 31795572 DOI: 10.3760/cma.j.issn.0578-1310.2019.12.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- W Wu
- Department of Pediatrics, Tongji Hospital of Huazhong University of Science and Technology, Wuhan 430030, China
| | - W Wu
- Department of Endocrinology, Children's Hospital of Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310052, China
| | - C X Gong
- Department of Endocrinology and Metabolic Disease, Beijing Children's Hospital of Capital Medical University, Beijing 100045, China
| | - Y Liang
- Department of Pediatrics, Tongji Hospital of Huazhong University of Science and Technology, Wuhan 430030, China
| | - M Zhu
- Department of Endocrinology, Children's Hospital of Chongqing Medical University, Chongqing 400014, China
| | - H Xiong
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| | - X P Luo
- Department of Pediatrics, Tongji Hospital of Huazhong University of Science and Technology, Wuhan 430030, China
| | - J F Fu
- Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
| |
Collapse
|
43
|
Bang YJ, Ruiz EY, Van Cutsem E, Lee KW, Wyrwicz L, Schenker M, Alsina M, Ryu MH, Chung HC, Evesque L, Al-Batran SE, Park SH, Lichinitser M, Boku N, Moehler MH, Hong J, Xiong H, Hallwachs R, Conti I, Taieb J. Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300. Ann Oncol 2019; 29:2052-2060. [PMID: 30052729 PMCID: PMC6225815 DOI: 10.1093/annonc/mdy264] [Citation(s) in RCA: 373] [Impact Index Per Article: 74.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022] Open
Abstract
Background There currently are no internationally recognised treatment guidelines for patients with advanced gastric cancer/gastro-oesophageal junction cancer (GC/GEJC) in whom two prior lines of therapy have failed. The randomised, phase III JAVELIN Gastric 300 trial compared avelumab versus physician’s choice of chemotherapy as third-line therapy in patients with advanced GC/GEJC. Patients and methods Patients with unresectable, recurrent, locally advanced, or metastatic GC/GEJC were recruited at 147 sites globally. All patients were randomised to receive either avelumab 10 mg/kg by intravenous infusion every 2 weeks or physician’s choice of chemotherapy (paclitaxel 80 mg/m2 on days 1, 8, and 15 or irinotecan 150 mg/m2 on days 1 and 15, each of a 4-week treatment cycle); patients ineligible for chemotherapy received best supportive care. The primary end point was overall survival (OS). Secondary end points included progression-free survival (PFS), objective response rate (ORR), and safety. Results A total of 371 patients were randomised. The trial did not meet its primary end point of improving OS {median, 4.6 versus 5.0 months; hazard ratio (HR)=1.1 [95% confidence interval (CI) 0.9–1.4]; P = 0.81} or the secondary end points of PFS [median, 1.4 versus 2.7 months; HR=1.73 (95% CI 1.4–2.2); P > 0.99] or ORR (2.2% versus 4.3%) in the avelumab versus chemotherapy arms, respectively. Treatment-related adverse events (TRAEs) of any grade occurred in 90 patients (48.9%) and 131 patients (74.0%) in the avelumab and chemotherapy arms, respectively. Grade ≥3 TRAEs occurred in 17 patients (9.2%) in the avelumab arm and in 56 patients (31.6%) in the chemotherapy arm. Conclusions Treatment of patients with GC/GEJC with single-agent avelumab in the third-line setting did not result in an improvement in OS or PFS compared with chemotherapy. Avelumab showed a more manageable safety profile than chemotherapy. Trial registration ClinicalTrials.gov: NCT02625623.
Collapse
Affiliation(s)
- Y-J Bang
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.
| | | | - E Van Cutsem
- Department of Digestive Oncology, University Hospitals Gasthuisberg/Leuven, KU Leuven, Leuven, Belgium
| | - K-W Lee
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea
| | - L Wyrwicz
- Department of Gastrointestinal Cancer, M. Sklodowska-Curie Memorial Cancer Center, Warsaw, Poland
| | - M Schenker
- Centrul de Oncologie Sf. Nectarie, Craiova, Romania
| | - M Alsina
- Department of Medical Oncology, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain
| | - M-H Ryu
- Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea
| | - H-C Chung
- Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Yonsei University Health System, Seoul, South Korea
| | - L Evesque
- Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France
| | - S-E Al-Batran
- Department of Clinical Oncology and Hematology, Krankenhaus Nordwest, Frankfurt, Germany
| | - S H Park
- Department of Medicine, Samsung Medical Center, Seoul, South Korea
| | - M Lichinitser
- Department of Chemotherapy and Combined Therapy, N. N. Blokhin Russian Oncological Scientific Center, Russian Academy of Medical Sciences, Moscow, Russian Federation
| | - N Boku
- Department of Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan
| | - M H Moehler
- Department of Internal Medicine, Johannes Gutenberg University Mainz, Mainz, Germany
| | - J Hong
- Global Clinical Development Immuno-Oncology, EMD Serono, Billerica, USA
| | - H Xiong
- Global Clinical Development Immuno-Oncology, EMD Serono, Billerica, USA
| | - R Hallwachs
- Global Research & Development, Merck KGaA, Darmstadt, Germany
| | - I Conti
- Global Clinical Development Immuno-Oncology, EMD Serono, Billerica, USA
| | - J Taieb
- Department of Gastroenterology and Digestive Oncology, Université Sorbonne Paris Cité, Paris Descartes University, Georges Pompidou European Hospital, Paris, France
| |
Collapse
|
44
|
Xiong H, Zheng W, Yu XF. Enhancing the anti-breast tumour activity of STING through a novel sting transcriptional regulator. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz418.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
45
|
Liu Y, Zheng Y, Gang Q, Xie Z, Jin Y, Zhang X, Deng X, Hao H, Gao F, Zhang Z, Xiong H, Zhang W, Wang Z, Yuan Y. Perimysial microarteriopathy in dermatomyositis with anti‐nuclear matrix protein‐2 antibodies. Eur J Neurol 2019; 27:514-521. [PMID: 31571350 DOI: 10.1111/ene.14097] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2019] [Accepted: 09/27/2019] [Indexed: 01/19/2023]
Affiliation(s)
- Y. Liu
- Department of Neurology Peking University First Hospital Beijing China
| | - Y. Zheng
- Department of Neurology Peking University First Hospital Beijing China
| | - Q. Gang
- Department of Neurology Peking University First Hospital Beijing China
| | - Z. Xie
- Department of Neurology Peking University First Hospital Beijing China
| | - Y. Jin
- Department of Pediatrics Peking University First Hospital Beijing China
| | - X. Zhang
- Department of Rheumatology and Clinical Immunology Peking University First Hospital Beijing China
| | - X. Deng
- Department of Rheumatology and Clinical Immunology Peking University First Hospital Beijing China
| | - H. Hao
- Department of Neurology Peking University First Hospital Beijing China
| | - F. Gao
- Department of Neurology Peking University First Hospital Beijing China
| | - Z. Zhang
- Department of Rheumatology and Clinical Immunology Peking University First Hospital Beijing China
| | - H. Xiong
- Department of Pediatrics Peking University First Hospital Beijing China
| | - W. Zhang
- Department of Neurology Peking University First Hospital Beijing China
| | - Z. Wang
- Department of Neurology Peking University First Hospital Beijing China
| | - Y. Yuan
- Department of Neurology Peking University First Hospital Beijing China
| |
Collapse
|
46
|
Lin G, Xu H, Zhao J, Kong J, Ai X, Yu F, Du K, Zhu L, Li L, Ma H, Wang Q, Xiong H, Chen R, Xia X. P2.14-09 Concurrent TP53 Mutation Adversely Impact the Efficacy of Crizotinib in ROS1-Rearranged Lung Cancer Patients. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.1794] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
47
|
Chen K, Lei Q, Xiong H, Chen Y, Luo W, Liang Y. A 2-year clinical evaluation of stainless steel crowns and composite resin restorations in primary molars under general anaesthesia in China's Guangdong province. Br Dent J 2019; 225:49-52. [PMID: 30002536 DOI: 10.1038/sj.bdj.2018.519] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/08/2018] [Indexed: 01/29/2023]
Affiliation(s)
- K Chen
- Stomatological Hospital, Southern Medical University, Guangzhou, China.,Department of Stomatology of Guangzhou Women and Children's Medical Center, Guangzhou, Guangdong, China
| | - Q Lei
- Shenzhen Hospital, Southern Medical University, Shenzhen, China
| | - H Xiong
- Department of Stomatology of Guangzhou Women and Children's Medical Center, Guangzhou, Guangdong, China
| | - Y Chen
- Department of Stomatology of Guangzhou Women and Children's Medical Center, Guangzhou, Guangdong, China
| | - W Luo
- Department of Stomatology of Guangzhou Women and Children's Medical Center, Guangzhou, Guangdong, China
| | - Y Liang
- Department of Stomatology of Guangzhou Women and Children's Medical Center, Guangzhou, Guangdong, China
| |
Collapse
|
48
|
Kling NG, Díaz-Tendero S, Obaid R, Disla MR, Xiong H, Sundberg M, Khosravi SD, Davino M, Drach P, Carroll AM, Osipov T, Martín F, Berrah N. Time-resolved molecular dynamics of single and double hydrogen migration in ethanol. Nat Commun 2019; 10:2813. [PMID: 31249306 PMCID: PMC6597707 DOI: 10.1038/s41467-019-10571-9] [Citation(s) in RCA: 21] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2018] [Accepted: 04/30/2019] [Indexed: 11/17/2022] Open
Abstract
Being the lightest, most mobile atom that exists, hydrogen plays an important role in the chemistry of hydrocarbons, proteins and peptides and most biomolecules. Hydrogen can undergo transfer, exchange and migration processes, having considerable impact on the chemical behavior of these molecules. Although much has been learned about reaction dynamics involving one hydrogen atom, less is known about those processes where two or more hydrogen atoms participate. Here we show that single and double hydrogen migrations occurring in ethanol cations and dications take place within a few hundred fs to ps, using a 3D imaging and laser pump-probe technique. For double hydrogen migration, the hydrogens are not correlated, with the second hydrogen migration promoting the breakup of the C-O bond. The probability of double hydrogen migration is quite significant, suggesting that double hydrogen migration plays a more important role than generally assumed. The conclusions are supported by state-of-the-art molecular dynamics calculations.
Collapse
Affiliation(s)
- Nora G Kling
- Department of Physics, University of Connecticut, Storrs, CT, 06269, USA.
| | - S Díaz-Tendero
- Departamento de Química, Módulo 13, Universidad Autónoma de Madrid, 28049, Madrid, Spain.
- Condensed Matter Physics Center (IFIMAC), Universidad Autónoma de Madrid, 28049, Madrid, Spain.
- Institute for Advanced Research in Chemical Sciences (IAdChem), Universidad Autónoma de Madrid, 28049, Madrid, Spain.
| | - R Obaid
- Department of Physics, University of Connecticut, Storrs, CT, 06269, USA
| | - M R Disla
- Department of Physics, University of Connecticut, Storrs, CT, 06269, USA
| | - H Xiong
- Department of Physics, University of Connecticut, Storrs, CT, 06269, USA
| | - M Sundberg
- Department of Physics, University of Connecticut, Storrs, CT, 06269, USA
| | - S D Khosravi
- Department of Physics, University of Connecticut, Storrs, CT, 06269, USA
| | - M Davino
- Department of Physics, University of Connecticut, Storrs, CT, 06269, USA
| | - P Drach
- Department of Physics, University of Connecticut, Storrs, CT, 06269, USA
| | - A M Carroll
- Department of Physics, University of Connecticut, Storrs, CT, 06269, USA
| | - T Osipov
- LCLS, SLAC National Accelerator Laboratory, Menlo Park, CA, 94025, USA
| | - F Martín
- Departamento de Química, Módulo 13, Universidad Autónoma de Madrid, 28049, Madrid, Spain.
- Condensed Matter Physics Center (IFIMAC), Universidad Autónoma de Madrid, 28049, Madrid, Spain.
- Instituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA-Nano), Campus de Cantoblanco, 28049, Madrid, Spain.
- Donostia International Physics Center (DIPC), Paseo Manuel de Lardizabal 4, 20018, Donostia-San Sebastián, Spain.
| | - N Berrah
- Department of Physics, University of Connecticut, Storrs, CT, 06269, USA.
| |
Collapse
|
49
|
Xu L, Xiong H, Shi W, Zhou F, Zhang M, Hu G, Mei J, Luo S, Chen L. Differential expression of sonic hedgehog in lung adenocarcinoma and lung squamous cell carcinoma. Neoplasma 2019; 66:839-846. [PMID: 31167533 DOI: 10.4149/neo_2018_181228n1002] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2018] [Accepted: 03/20/2019] [Indexed: 11/08/2022]
Abstract
Overexpression of Sonic hedgehog (Shh) is associated with progression of several cancers. The expression of Shh in non-small cell lung cancer (NSCLC) has been reported with inconsistent results. Lung adenocarcinoma (LAC) and lung squamous cell carcinoma (LSCC) are two major subtypes of NSCLC, which have different genetic genotypes and clinical therapeutic options. The expression of Shh in specimen of patients with NSCLC has yet to be comprehensively determined according to histological subtypes. Shh expression level was determined in 167 NSCLC patients (56 LAC patients and 111 LSCC patients) by immunohistochemical assay (IHC) and disease-free survival and overall survival of patients were analyzed using the Kaplan-Meier method. Shh protein level in pleural effusion from patients with pneumonia or pleural empyema, tuberculosis, LAC and LSCC was measured with enzyme-linked immunoassay (ELISA). We found that Shh expression is increased in tumor tissues from both LAC and LSCC patients compared with the paired adjacent tissues, while Shh level is negatively correlated with tumor differentiation only in LSCC, LSCC patients containing higher-Shh expression have a poorer prognosis. Furthermore, Shh level is elevated in pleural effusion from LSCC patients compared with that of parapneumonic and LAC pleural effusion. Shh expression in tumor tissues or pleural effusion may represent a potential diagnostic and prognostic marker of LSCC patients, pleural effusion Shh may assist to distinguish between LAC and LSCC.
Collapse
Affiliation(s)
- L Xu
- Center for Experimental Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, China
| | - H Xiong
- Center for Experimental Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, China
| | - W Shi
- Center for Experimental Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, China
| | - F Zhou
- Center for Experimental Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, China
| | - M Zhang
- Center for Experimental Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, China
| | - G Hu
- Center for Experimental Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, China
| | - J Mei
- Department of Pathology, The First Affiliated Hospital of Nanchang University, Nanchang, China
| | - S Luo
- Center for Experimental Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, China
| | - L Chen
- Center for Experimental Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, China
| |
Collapse
|
50
|
Xiong H, Jiang M, Zhang W, Ye H, Chen Z, Zeng F, Chen S, Xing Q, Luo X. 994 Risk and association of HLA alleles with methimazole induced cutaneous adverse reactions in Chinese Han population. J Invest Dermatol 2019. [DOI: 10.1016/j.jid.2019.03.1070] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|